Cargando…

Human Th17 cells in patients with cancer: Friends or foe?

The role of interleukin-17 (IL-17)-secreting CD4(+) T (Th17) cells in cancer is under intense investigation. We have demonstrated that CCR4(+)CCR6(+) Th17 cells not only are increased in the peripheral blood of patients affected by hepatocellular carcinoma, but also suppress CD8(+) T-cell functions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greten, Tim F., Zhao, Fei, Gamrekelashvili, Jaba, Korangy, Firouzeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518530/ https://www.ncbi.nlm.nih.gov/pubmed/23243621 http://dx.doi.org/10.4161/onci.21245

Ejemplares similares

Tissue-resident memory T cells in immune-related adverse events: friend or foe?
por: Reschke, Robin, et al.
Publicado: (2023)

Friend or foe: A novel role of β-defensins in tumor development
por: Röhrl, Johann, et al.
Publicado: (2012)

Primary sterile necrotic cells fail to cross-prime CD8(+) T cells
por: Gamrekelashvili, Jaba, et al.
Publicado: (2012)

Dipeptidyl peptidase 3 and thimet oligopeptidase 1 knockdown support tumor-specific immune responses to whole cell cancer vaccines and tumor cell death in vivo
por: Gamrekelashvili, Jaba, et al.
Publicado: (2013)

Interleukin-21 in cancer immunotherapy: Friend or foe?
por: Stolfi, Carmine, et al.
Publicado: (2012)

Neuroprotective actions of 2,4-dinitrophenol: Friend or foe?
por: Ferreira, Sérgio Teixeira, et al.
Publicado: (2007)

Th17 Cells in Viral Infections—Friend or Foe?
por: Paiva, Iury Amancio, et al.
Publicado: (2021)

Cancer-associated fibroblasts and macrophages: Friendly conspirators for malignancy
por: Chiarugi, Paola
Publicado: (2013)

New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunity
por: Guéry, Leslie, et al.
Publicado: (2015)

Friend or foe: How plants discriminate between pathogenic and mutualistic bacteria
por: Calla, Bernarda
Publicado: (2022)

The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
por: Gamal, Wael, et al.
Publicado: (2022)

Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells
por: Medina-Echeverz, Jose, et al.
Publicado: (2013)

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells
por: Lankiewicz, Silke, et al.
Publicado: (2008)

IL-17A is a central regulator of lung tumor growth
por: Reppert, Sarah, et al.
Publicado: (2012)

Spatiotemporal plasticity of miRNAs functions: The miR-17-92 case
por: Bonaldi, Tiziana, et al.
Publicado: (2016)

Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?
por: Wen, Liang, et al.
Publicado: (2016)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis
por: Bastid, Jérémy, et al.
Publicado: (2014)

Barrett's esophagus stages: their correlation with SBS17-associated DNA mutations and the identification of histological marker genes
por: Busslinger, Georg A.
Publicado: (2022)

Is tumor (R)ejection by the immune system the “5th R” of radiobiology?
por: Golden, Encouse B, et al.
Publicado: (2014)

Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage
por: Eggert, Tobias, et al.
Publicado: (2014)

IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
por: Kuen, Da-Sol, et al.
Publicado: (2020)

Friend and Foe
Publicado: (1890)

Cricoid pressure – friend or foe?
por: Harris, Tim, et al.
Publicado: (2009)

The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014)

Identification of human tissue cross-presenting dendritic cells: A new target for cancer vaccines
por: Haniffa, Muzlifah, et al.
Publicado: (2013)

When defense turns into attack: Antiviral cytidine deaminases linked to somatic mutagenesis in HPV-associated cancer
por: Henderson, Stephen, et al.
Publicado: (2014)

Oncogenic long noncoding RNA FAL1 in human cancer
por: Zhong, Xiaomin, et al.
Publicado: (2015)

The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019)

Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019)

Chemokines and Cancer: Friends or Foes?
por: Strazza, Marianne, et al.
Publicado: (2020)

Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021)

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

Identification of human inflammatory dendritic cells
por: Segura, Elodie, et al.
Publicado: (2013)

Symmetry breaking in human neuroblastoma cells
por: Izumi, Hideki, et al.
Publicado: (2014)

Tumor-associated macrophages in lung cancer: Friend or foe?
por: Xu, Fei, et al.
Publicado: (2020)

T Cells in Gastric Cancer: Friends or Foes
por: Amedei, Amedeo, et al.
Publicado: (2012)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

Cell-in-cell structures are involved in the competition between cells in human tumors
por: Sun, Qiang, et al.
Publicado: (2015)

PD-L1 immune suppression in cancer: Tumor cells or host cells?
por: Kleinovink, Jan Willem, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ul5qo9330pdcmoa5qursdj3ljh